| Jun 10 |
Lilly's donanemab effective for Alzheimer's disease, FDA advisors say (updated)
|
| Jun 10 |
Weight loss drugs other benefits could convince more men to use them - report
|
| Jun 10 |
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
|
| Jun 10 |
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
|
| Jun 10 |
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
|
| Jun 10 |
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
|
| Jun 8 |
Lilly's donanemab, remternetug set to dominate Alzheimer's treatment by 2030
|
| Jun 8 |
The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?
|
| Jun 8 |
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks
|
| Jun 7 |
Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
|
